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Abstract: A 25-year-old man had complained of sudden fever spikes for two years and his blood 
tests were within the normal range. In 1993, a surgical biopsy of swollen left inguinal lymph 
nodes was negative for malignancy, but showed reactive lymphadenitis and widespread sinus 
histiocytosis. A concomitant needle biopsy of the periaortic lymph nodes and a bone marrow 
aspirate were also negative. In 1994, after an emergency hospital admission because of a sport-
related thoracic trauma, a right inguinal lymph node biopsy demonstrated Hodgkin’s lymphoma 
Stage IVB (scleronodular mixed cell subtype). Although it was improved by chemotherapy, the 
disease suddenly relapsed, and a further lymph node biopsy was performed in 1998 confirming 
the same diagnosis. Despite further treatment, the patient died of septic shock in 2004, at the 
age of 38 years. Retrospective analysis of the various  specimens showed  intracellular heavy 
metal nanoparticles within lymph node, bone marrow, and liver samples by field emission gun 
environmental scanning electron microscopy and energy dispersive  spectroscopy. Heavy metals 
from environmental pollution may accumulate in sites far from the entry route and, in genetically 
conditioned individuals with tissue specificity, may act as  cofactors for chronic inflammation 
or even malignant transformation. The present anecdotal report highlights the need for further 
pathologic ultrastructural investigations using serial samples and the possible role of intracel-
lular nanoparticles in human disease.
Keywords: Hodgkin’s lymphoma, heavy metals, nanoparticles, nanotoxicity, host–particle 
interactions, environmental exposure
Introduction
Environmental pollution and occupational exposure to heavy metals are considered 
possible cofactors in the occurrence of both chronic and malignant diseases. The bulk 
of epidemiologic and in vitro studies, as well as studies in experimental animals, sup-
port the hypothesis that a cause and effect relationship exists between chronic irritation 
(oxidative stress) by heavy metals and carcinogenesis. Unfortunately, there is a complete 
lack of relevant human studies, in particular concerning pathologic examination of 
serial samples collected at various time intervals and showing host–particle interaction 
at the ultrastructural level.
Hodgkin’s disease is a malignant systemic lymphoma which affects a large number 
of young people. Its occurrence has been occasionally related to viral pathogenesis 
because of the prevalence of Epstein–Barr virus infection in different types and loca-
tions of lymphoma.1–4 Sometimes the clinical history starts with remitting episodes of 
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fever followed by lymph node swelling, biopsy and pathologic 
examinations, which detects typical malignant  degeneration, 
with Reed–Sternberg cells spreading into the infiltrated 
lymphoreticular network. The progression from nonspecific 
lymphadenitis to lymphoma is seldom  histologically depicted 
because of the speed of transformation.
Our case report describes a 25-year-old man who, at the 
beginning of his disease, had lymph node enlargement for at 
least one year and underwent repeated biopsy of the nodes 
and bone marrow until a diagnosis of Hodgkin’s lymphoma 
was finally made.
We have investigated the possibility of a link between 
exposure to environmental particulate matter and develop-
ment of lymphoma5,6 using a new investigational tool, ie, field 
emission gun-environmental scanning electron microscopy 
(FEG-ESEM) coupled with energy dispersive spectroscopy 
(EDS) to determine the chemical composition of the particles 
identified. We have investigated nanoparticle storage in lymph 
nodes and involved tissues retrospectively. This research has 
highlighted the presence of heavy metal nanoparticles in cells 
and opens the debate on their pathogenetic role in the onset 
of Hodgkin’s disease.
Case report
This investigation has been performed in a young  European 
male (1967–2004). He was a racing car driver who was 
regularly exposed to toxic air pollution. In 1985, the patient 
underwent appendectomy for acute appendicitis with 
 moderate leukocytosis (white blood cells).4,10 Two years 
later, he suffered from head and spine trauma, followed by 
a motorbike accident the following year. The latter led to a 
fracture of the left tibia which was surgically treated with a 
titanium pin.
In May 1993, the patient was hospitalized due to an unre-
mitting fever (37.5°C) which lasted for one month. A labora-
tory analysis was performed, and the results were negative 
for cytomegalovirus, pathogenic fecal bacteria, HIC, human 
immunodeficiency virus, Epstein–Barr virus, Brucella, 
Shigella, and Salmonella typhimurium, but a toxoplasmosis 
test was positive, and a computed tomography scan showed 
enlarged paraortic lymph nodes and an enlarged left inguinal 
lymph node. A needle biopsy of the periaortic lymph nodes 
and a bone marrow biopsy showed an inflammatory mixed 
cell response.
In July 1993, the surgical biopsy of a left inguinal 
node led to the diagnosis of reactive lymphadenitis with 
 widespread immature sinus histiocytosis, but without para-
cortical  tissue enlargement and a normal immunophenotype. 
In February 1994, the tibial pin was removed and,  following 
the operation, the fever disappeared. Five months later, the 
radiogallium lymph node scintigraphy suggested a pos-
sible diagnosis of sarcoidosis. Two months later, the patient 
 suffered a sports-related thoracic trauma which resulted 
in an emergency hospital admission. A plain chest X-ray 
showed bilateral hilar polycyclic lymphadenopathy with right 
upper and middle lobe infiltration, raising the suspicion of 
 lymphoma. A bone marrow biopsy showed a pattern related 
to chronic infections and atypical lymphocytes (less than 5%), 
whereas a right inguinal lymph node biopsy showed weakly 
positive Leu M1 Reed–Sternberg cells. Lymphatic cells were 
UCHL1- and CD3-positive (T lymphocytes), and a  minority 
were L26-positive (B lymphocytes). Finally, Hodgkin’s 
 lymphoma Stage IVB (scleronodular mixed cell subtype) was 
diagnosed. The patient underwent  radiochemotherapy with 
partial volumetric regression of the right  thoracic paraortic 
lymph nodes.
In 1997, further lesions were found in the spleen. The total 
body positron emission tomography revealed the involve-
ment of the liver at the VII segment level, confirmed by an 
 ultrasound scan showing additional lesions at the V, VII, and 
VIII  segments. Histologic analysis of the ultrasound-guided 
liver biopsy showed Reed–Sternberg cell infiltration.
In June 1998, a computed tomography (CT) scan showed 
relapse of the thoracic lesions. The patient was treated with 
rituximab. Despite  treatment, the disease progressed with 
bone involvement. In late November 1998, a further lymph 
node biopsy  confirmed the presence of Hodgkin’s disease 
( scleronodular mixed cell subtype). The patient died of septic 
shock in May 2004.
Materials and methods
Tissue samples analyzed included a left inguinal lymph node 
in 1993, a right lymph node in the groin area in 1994, a bone 
marrow biopsy in 1994, and another lymph node in 1998. 
Biopsy samples of benign (on the right) and malignant (on 
the left) lymph nodes and bone marrow were fixed in 10% 
formalin,  dehydrated in ascending concentration alcohols, 
and  embedded in paraffin. A Leica microtome (RM 2125RT; 
Lecia Nussloch, Germany) was used to cut biopsy sections 
10 µ in thickness. The sections were deposited on an acetate 
sheet and deparaffined with xylol. After that, with a few drops 
of xylol and 98% alcohol, they were mounted on an aluminum 
stub and inserted inside the chamber of a FEG-ESEM Quanta 
(FEI Company, Eindhoven, The Netherlands) coupled with an 
EDS (EDAX, Mahwah, NJ). The use of the FEG-ESEM was 
 recommended because it does not need any further process to 
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Table 1 Type, chemical composition, and size of particles identified in lymph node samples*
Samples Diagnosis Chemical composition of particles Size (μ)
right inguinal 
lymph node (1993)
reactive 
lymphadenitis,  
no lymphoma
Calcification Ca, C, O, P, S, Si, Mg, Cl, N, 
Na; gold compound C, Au, O, Cl, N, Ca, 
Na, Fe, Cu, Ni
Agglomerate 
1.00–2.00
Left lymph node  
in groin area (1994)
Hodgkin’s lymphoma Calcification C, Ca, O, Si, Al, P, Cl, S, Mg; 
chromium compound C, O, Cr, N, Cl, s, P; 
iron compounds C, Fe, O, Cl, s, si, Ca, P, 
Ba, C, O, Fe, s, N, P, Cl, si, Al, Cu, Ca, sn, Zn
5.00 
2.00 
1.00 
1.5
Bone marrow 
biopsy (1994)
Bone marrow biopsy 
revealed an active 
inflammatory process 
stainless steel C, O, Fe, Cr, Cl, P, N, s, si, Ni; 
calcification C, Ca, O, S, P, N; iron compound 
Fe, C, si, O, Ca, Cl, s, Mn, P, Cu, N
0.2–5 
1–4 
2–4
Note: *Elements are shown according to the energy dispersive spectroscopy peaks, from highest to lowest.
make the sample electron-conductive (gold or carbon coat-
ing of the biologic sections). The EDS microanalysis system 
was used to identify the elemental composition of inorganic 
materials (foreign bodies) identified in the biopsy samples. 
The working conditions of the FEG-ESEM were low-vacuum, 
from 20 to 30 kV, in secondary and backscattered electron 
modality, with spots 3–5. For every sample, a list of the par-
ticles found in the sample was given, along with their size, 
morphology, and chemical composition.
Discussion
Microsized and nanosized foreign bodies have been identi-
fied in all the samples analyzed. Table 1 shows a summary 
of the most representative particles identified in the lymph 
node and bone marrow biopsies, taken at different stages 
of the disease, described according to morphology, size 
and chemical composition. Particle accumulation is not 
uniform, and this might have been due to asymmetry of the 
lymphatic circulation. The debris consists of heavy metals, 
including stainless steel and chromium compounds. These 
are not biocompatible and, over time, release highly toxic 
ions, including iron, chromium, and nickel. Our  investigation 
shows an increased amount of metallic foreign bodies, with 
progression of the disease and progressive amounts of sub-
microscopic calcium storage.7
Chromium compounds produce a variety of types of 
DNA damage, including single-strand breaks, alkali-labile 
sites, and DNA protein crosslinks. These compounds bind 
isolated DNA and proteins, readily enter cells via anion 
 channels, but do not cross cell membranes. Chromium 
inhibits the transcriptional activity of nuclear factor-kappa B 
by decreasing the interaction of p65 with cAMP-responsive 
element-binding protein.8,9
Figure 1 shows submicronic particles (white spots) in the 
left lymph node biopsy sample. These particles appear whiter 
than the biologic substrate because they are  atomically denser. 
The biologic tissue is only composed of carbon,  oxygen, 
 phosphorus, sulphur, and chlorine, whereas the  particles 
 contain chromium with traces of calcium.  Chromium is 
 chemically toxic in biologic tissue and can also release 
 chromium ions which worsen the toxicity.10–13 Raised 
 concentrations of  circulating metal degradation  products, 
derived from  orthopedic implants, may have deleterious 
biologic effects over time. Accurate monitoring of metal 
concentrations in serum and urine, after total hip  replacement, 
can provide insights into the mechanisms of metal release. 
 Corrosion  significantly raises metal levels, including nickel 
and  chromium in serum and urine, when compared with 
patients with no radiologic evidence of corrosion and 
 volunteers without metallic implants (P , 0.001).14–18  Samples 
of the progression of the disease are shown in  Figures 2 and 
3. A progressively increasing number of  microsized and 
nanosized metallic particles have been found.
Our case report describes for the first time a pathophysio-
logic and ultrastructural five-year follow-up of lymph nodes 
obtained from the same patient. It shows the progressive 
storage of heavy metal nanoparticles in lymphatic tissue, 
which was in parallel with progression of a cancerous  process 
from early chronic inflammation to Hodgkin’s disease. This 
is a unique case report relating to one-year progression 
from lymphadenitis to lymphoma in the inguinal region of a 
patient, where the increasing presence of foreign inorganic 
 microsized and nanosized bodies has been demonstrated. 
Although the patient underwent appendectomy and tested 
positive for  toxoplasmosis which may be  associated with 
malignancies, this relationship was unlikely in our patient. His 
 appendectomy dated back to childhood, and  toxoplasmosis 
did not lead to infection with encephalic damage. Further-
more, we found no evidence of immunosuppression during 
the lymphoma incubation period.
Heavy metals, such as iron, chromium and nickel, are 
the main constituents of foreign bodies found in cells.9,11,19–21 
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Figure 2 The microphotograph shows the analyses carried out on the right 
lymph-node with the eDs spectrum on the chemical composition of the debris. 
Nanoparticles of iron, chromium, and silicon are identified.
Figure 3 The bone marrow sample shows the presence of many nanoparticles 
(range 150 nm–5 µm) composed of iron, chromium, and nickel, namely debris of 
stainless steel.
Occupational or incidental heavy exposure to many 
 chemicals, including benzene, pesticides, ethylene oxide and 
 metals (mercury, cadmium, chrome, cobalt, lead, aluminum) 
is very dangerous for the hematopoietic system. Mercury and 
chromium cause immunosuppression and evoke autoimmune 
reactions.10–12,22–25
An epidemiologic study assessing cancer risk in a small 
population exposed to excessive amounts of chromium9 
reported two cases of Hodgkin’s disease after protracted 
exposure and a long latency period. The calculated and 
observed risk in this study is 65–92-fold higher than in 
nonexposed populations. Clinicians should be aware of the 
potential association between hexavalent chromium exposure 
and Hodgkin’s lymphoma.
The particles have been identified as foreign bodies arising 
from environmental pollution. Their identification in anatomic 
areas, far from the putative route of entry, raises the issues of 
whether the mechanism of entrance, internal distribution (stream-
ing), and uptake (selective or not) in the human body involves a 
potential respiratory or digestive source, and the potential patho-
genic mechanism by which nonbiocompatible nanosized foreign 
bodies cause a chronic inflammatory reaction in lymphatic tissue 
progressing to Hodgkin’s lymphoma.11,19,21,26
The possibility of environmental pollutants spreading 
inside the body after inhalation has been shown by Péry et al27 
in a study involving five volunteers after  inhalation of 
technetium-radiolabeled 100 nm carbon particles. They dem-
onstrated that these radiolabeled nanoparticles overwhelm 
the lung barrier within 60 seconds and are stored in the liver 
within 60 minutes. After this time, the radioactive signal 
decreases, but there can be a wider dispersion through the 
blood circulation. Evidence of submicronic particles spread-
ing in different organs or regions, including sperm and brain 
tissue, has been shown previously. The transport of nanosized 
particles, due to their consistently small size, may be medi-
ated by blood cells or other blood or lymph components. 
The toxicologic pathway can be identified in the absence of 
biocompatibility. In particular, metal nanoparticles may pro-
duce toxic ions locally by delayed corrosion mechanisms.14–18 
Trapping of these nanoparticles within lymphatic cells, with 
mutagenic and carcinogenic potential via an inflammatory 
reaction, could elicit a cytokine cascade and lymph node 
engulfment, with further critical concentration of nanomateri-
als up to the level inducing carcinogenic mutations.
With regard to the present case report, it would have 
been helpful if the patient had been followed up during the 
five years preceding 1993, ie, when the progression from 
chronic inflammation to cancerous disease actually occurred. 
However, it is important to bear in mind the difference 
between experimental research using animal models and that 
using human subjects, whereby the latter must conform to 
more stringent ethical rules. In the absence of more robust 
data on humans  demonstrating a clear-cut cause and effect 
relationship between chronic exposure to heavy metals and 
malignancies (not only on the basis of epidemiologic cor-
Figure 1 The microphotograph shows two submicronic particles (the white 
spots) embedded in the left lymph-node biopsy sample. The eDs spectrum shows 
the chemical composition: carbon, oxygen, chromium, phosphorus, sulfur, and 
chlorine.
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relation studies, but on the basis of pathologic evidence, such 
as in the  present report), we believe that the present case 
report could be  useful to the scientific community. However, 
caution is recommended when interpreting the results of a 
single case report, as well as those of small studies such as 
that one by Bick et al,11 in which small numbers could be 
responsible for bias in risk calculation. In addition, as our 
extended studies have already suggested,5,6,28–33 environmental 
pollutants are usually present in such a small concentration 
in the atmosphere that they are unlikely to be solely respon-
sible for the occurrence of malignant disease in the absence 
of a congenital or inherited predisposition in the host. On 
the contrary, in the presence of frail predisposed subjects, 
even small amounts of pollutants could be cofactors for the 
occurrence of chronic or even malignant diseases.1
Our anecdotal report highlights the need for ultrastructural 
investigation in a larger sample of patients with Hodgkin’s lym-
phoma. It suggests the possibility that, at least in some subtypes, 
or in a proportion of subjects with Hodgkin’s disease, the pro-
gression from chronic lymphadenitis to overt malignancy can be 
facilitated or codetermined in addition to genetic or congenital 
factors. Moreover, it is likely to happen by chronic exposure or 
accumulation of heavy metal nanoparticles within lymph nodes, 
which could determine additional carcinogenetic mutations.
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